SGLT-2is Edge GLP-1 RAs on Foot Disease - Quiz - MDSpire

SGLT-2is Edge GLP-1 RAs on Foot Disease

Danish target trial emulation finds modest neuropathy benefit emerging following year 3, but high discontinuation rates complicate causal interpretation

  • By

  • Kerri Miller

  • January 5, 2026

  • 5 min

Share

Original Source(s)

SGLT-2is Edge GLP-1 RAs on Foot Disease

  • by Kerri Miller

  • January 5, 2026

Related Content

An epidemiological assessment of the distribution and sociodemographic burden of chronic diseases: a focus on hypertension, diabetes, and cardiovascular conditions

FDA Monthly Preview: Key June Decisions to Watch

Several FDA decisions across multiple specialties are expected this month.

Impact of body mass index on outcomes of cardiac rehabilitation: a systematic review and meta-analysis